These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 28851034)

  • 1. MDA, MDMA, and other "mescaline-like" substances in the US military's search for a truth drug (1940s to 1960s).
    Passie T; Benzenhöfer U
    Drug Test Anal; 2018 Jan; 10(1):72-80. PubMed ID: 28851034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in the stimulus properties of 3,4-methylenedioxyamphetamine and 3,4- methylenedioxymethamphetamine in animals trained to discriminate hallucinogens from saline.
    Callahan PM; Appel JB
    J Pharmacol Exp Ther; 1988 Sep; 246(3):866-70. PubMed ID: 2901488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of the MDA and MDMA optical isomers in a stimulant-hallucinogen discrimination.
    Baker LE; Taylor MM
    Pharmacol Biochem Behav; 1997 Aug; 57(4):737-48. PubMed ID: 9259001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optical isomer analysis of 3,4-methylene-dioxyamphetamine analogues and their stereoselective disposition in rats.
    Matsushima K; Nagai T; Kamiyama S
    J Anal Toxicol; 1998; 22(1):33-9. PubMed ID: 9491966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the enantiomers of 3,4-methylenedioxy-N-ethylamphetamine (MDE, "Eve") and its metabolite 3,4-methylenedioxyamphetamine (MDA) in rat brain.
    Hegadoren KM; Baker GB; Coutts RT
    J Pharmacol Toxicol Methods; 1995 Oct; 34(2):117-23. PubMed ID: 8563033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increasing use of "Ecstasy" (MDMA) and other hallucinogens on a college campus.
    Cuomo MJ; Dyment PG; Gammino VM
    J Am Coll Health; 1994 May; 42(6):271-4. PubMed ID: 7913938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lifetime use of MDMA/ecstasy and psilocybin is associated with reduced odds of major depressive episodes.
    Jones GM; Nock MK
    J Psychopharmacol; 2022 Jan; 36(1):57-65. PubMed ID: 34983261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adam and Eve make love. Analysis of the enantiomers of 3,4-methylenedioxy-N-ethylamphetamine (MDE, "Eve") and its metabolite 3,4-methylenedioxyamphetamine (MDA) in rat brain.
    Tucker G
    Hum Exp Toxicol; 1996 May; 15(5):455-7. PubMed ID: 8735473
    [No Abstract]   [Full Text] [Related]  

  • 9. Dark Classics in Chemical Neuroscience: 3,4-Methylenedioxymethamphetamine.
    Dunlap LE; Andrews AM; Olson DE
    ACS Chem Neurosci; 2018 Oct; 9(10):2408-2427. PubMed ID: 30001118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of metabolism in 3,4-(+)-methylenedioxyamphetamine and 3,4-(+)-methylenedioxymethamphetamine (ecstasy) toxicity.
    Monks TJ; Jones DC; Bai F; Lau SS
    Ther Drug Monit; 2004 Apr; 26(2):132-6. PubMed ID: 15228153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (+)-N-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine as a discriminative stimulus in studies of 3,4-methylenedioxy-methamphetamine-like behavioral activity.
    Oberlender R; Nichols DE
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1098-106. PubMed ID: 1979813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemistry and pharmacology of hallucinogens, entactogens and stimulants.
    Kovar KA
    Pharmacopsychiatry; 1998 Jul; 31 Suppl 2():69-72. PubMed ID: 9754836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MDA-MDMA concentrations in urine specimens.
    Kunsman GW; Levine B; Kuhlman JJ; Jones RL; Hughes RO; Fujiyama CI; Smith ML
    J Anal Toxicol; 1996; 20(7):517-21. PubMed ID: 8934299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mass spectrometry data of some metabolites of the amphetamine derivatives 3,4-(methylenedioxy) amphetamine (MDA) and 3,4-methylenedioxy)methylamphetamine (MDMA)].
    Verweij AM
    Arch Kriminol; 1996; 197(1-2):27-30. PubMed ID: 8851250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Entactogenic drugs "ecstasy" (MDMA), "eve" (MDE) and other ring-substituted methamphetamine derivatives. A new class of substances among illegal designer drugs?].
    Gouzoulis-Mayfrank E; Hermle L; Kovar KA; Sass H
    Nervenarzt; 1996 May; 67(5):369-80. PubMed ID: 9005345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-pressure liquid chromatography/electrochemical detection method for monitoring MDA and MDMA in whole blood and other biological tissues.
    Michel RE; Rege AB; George WJ
    J Neurosci Methods; 1993 Oct; 50(1):61-6. PubMed ID: 7903993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple drug ingestion by ecstasy abusers in the United States.
    Black DL; Cawthon B; Robert T; Moser F; Caplan YH; Cone EJ
    J Anal Toxicol; 2009 Apr; 33(3):143-7. PubMed ID: 19371462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of drugs at 'raves'.
    Brown ER; Jarvie DR; Simpson D
    Scott Med J; 1995 Dec; 40(6):168-71. PubMed ID: 8693332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the Psychedelic Amphetamine MDA (3,4-Methylenedioxyamphetamine) in Healthy Volunteers.
    Baggott MJ; Garrison KJ; Coyle JR; Galloway GP; Barnes AJ; Huestis MA; Mendelson JE
    J Psychoactive Drugs; 2019; 51(2):108-117. PubMed ID: 30967099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurotoxicity mechanisms of thioether ecstasy metabolites.
    Capela JP; Macedo C; Branco PS; Ferreira LM; Lobo AM; Fernandes E; Remião F; Bastos ML; Dirnagl U; Meisel A; Carvalho F
    Neuroscience; 2007 Jun; 146(4):1743-57. PubMed ID: 17467183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.